Diabetes is on the rise in children and young people

Published Date: 10 Mar 2023

New findings from researchers at Wake Forest University School of Medicine show that the rate of type 1 and type 2 diabetes is increasing...

Read Full News

Latest News

Remote Program Aids Obesity Medication Access

Pharmacists and navigators can expand obesity drug access without doctor visits — but drug shortages, insurance hurdles, and paperwork, not patient willingness, are the real bottlenecks to scale.

India Wanted Red Flags on Chip Packets and Soda. Big Food Fought Back

A can of Fanta sold in London has 63 calories. Buy the same brand in India, and it contains three times as much sugar. It also includes artificial dye, whose presence in...

FDA OKs Gene Therapy for Glycogen Storage Disease Type Ia

The FDA grants accelerated approval for the innovative, one-time gene therapy Genglycos to treat the rare disease GSDIa in children aged 8 years and older and adults.

Diabetes Prevention Starts Earlier Than Thought

An expert panel says diabetes prevention should start long before hyperglycemia, with risk shaped across pregnancy, childhood, and adulthood.

Does Telehealth-Only GLP-1 Care Fall Short?

Many vital tests and evaluations a patient needs before and after starting GLP-1s can’t be done over the computer.

Partner Weight Loss Increases When Included in Program

A behavioral weight-loss program aimed at one partner can produce meaningful, lasting weight loss in the other — despite never asking them to change their own habits.

Todays Updates

Sequencing Method Flags AML Relapse Risk Around Transplant

High-sensitivity tracking of a high-risk mutation may help identify risk for relapse in patients with acute myeloid leukemia around the time of allogeneic transplant.

Todays Updates

Sequencing Method Flags AML Relapse Risk Around Transplant

High-sensitivity tracking of a high-risk mutation may help identify risk for relapse in patients with acute myeloid leukemia around the time of allogeneic transplant.

Latest News

Pharmacists and navigators can expand obesity drug access without doctor visits — but drug shortages, insurance hurdles, and paperwork, not patient willingness, are the real bottlenecks to scale.

A can of Fanta sold in London has 63 calories. Buy the same brand in India, and it contains three times as much sugar. It also includes artificial dye, whose presence in...

The FDA grants accelerated approval for the innovative, one-time gene therapy Genglycos to treat the rare disease GSDIa in children aged 8 years and older and adults.

An expert panel says diabetes prevention should start long before hyperglycemia, with risk shaped across pregnancy, childhood, and adulthood.

Many vital tests and evaluations a patient needs before and after starting GLP-1s can’t be done over the computer.

A behavioral weight-loss program aimed at one partner can produce meaningful, lasting weight loss in the other — despite never asking them to change their own habits.

News All Time

Even Short Bouts of Antipsychotics Linked to Diabetes Risk

Risks rose through year 5 in youths, but were seen after even just 1 year

Surgery Underused for Primary Hyperparathyroidism With End-Organ Damage, Study Says

Large study highlights gap between guidelines and clinical practice

Study on Vaginal Estrogen for UTI Prevention Backs a Less Messy Approach

Periurethral and intravaginal creams both aided prevention of recurrent urinary tract infections

Florida Investigates Fauci; Obesity Drug Trial Sparks Lawsuit; 'Early Bird' Dinners

Health news and commentary gathered by MedPage Today staff

NFL Pro Bowler Has Parkinson's; RFK Jr.'s Cooking Show; GLP-1s and Pregnancy

Health news and commentary gathered by MedPage Today staff

Outbreak Deaths Near 1,600; GLP-1 Temporal Hollowing; Hospitals Get Pay Bump

Health news and commentary gathered by MedPage Today staff

Bone Density Appears to Rebound in Transgender Youth After Puberty Blockers Are Done

Meta-analysis turns up partial recovery after gender-affirming hormone therapy is started

Evolving Landscape for Managing Cardiovascular, Renal and Metabolic Conditions

Evolving Landscape for Managing Cardiovascular, Renal and Metabolic Conditions

Is 'Gym Penis' Real? Retatrutide Access Expanded; Vitamin D Fails Cancer Test

Health news and commentary gathered by MedPage Today staff

ADA Reviewing Police Tussle; Obesity Trial Lawsuit; Retatrutide's Early Access

News and commentary from the endocrinology world

Study Points to How Vegan Diets May Aid in Weight Loss

Don't "eat less," but "eat differently," researcher advises

Ozempic Teeth, Muscle Loss: Some of the Buzziest GLP-1 Side Effects

Weight-loss drugs have lots of benefits, and lots of potential side effects

Deaths After GLP-1s; First Detransition Clinic for Youths; DXA Scans Decline

News and commentary from the endocrinology world

GLP-1 Telehealth Platforms Rated by U.S. News

New ratings come amid soaring GLP-1 demand

Alzheimer's Risk Lower for Women on Estrogen-Only Menopausal Hormone Therapy

More than 20 years after landmark trial, hormone replacement treatment remains controversial

Medicaid to Stop Paying for Some Gender-Affirming Care for Youth

The announcement is latest in a series of policies aimed at transgender people

Recommended News For You

Mental health risk persists years after cancer diagnosis

Specific suicidal patterns mark the highest risk.

Efficacy and safety of intravenous chemotherapy in children with intraocular retinoblastoma

Subcutaneous Cancer Immunotherapies Provide New Options for Physicians and Patients

Compared to previous estimates, a greater number of patients participate in cancer treatment trials.

Review looks at potential treatment targets in the tumor microenvironment.

Telisotuzumab vedotin shows durable response in some Asian patients with nonsquamous NSCLC

Recommended Articles For You

Revolutionizing Cancer Care: The Promise of Early Detection and Biomarkers 

Landmark Medical Oncology Trials Redefining Early Breast Cancer Management 

Clinical Pharmacology of Drug Exposure During Long-Term Cancer Survivorship 

A Closer Look at MCV Modules: Features, Functions, and Benefits  

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Morning Immunotherapy Does Not Boost Lung Cancer Survival

2.

Adopted cancer cells and the effects of their presence.

3.

Contradictory Results Are Found in Two Pembrolizumab Trials for Head and Neck Cancer.

4.

Scientists are investigating the prevention of recurrent breast cancer, which frequently results in death.

5.

What Could This Exploratory 5-Year Survival Data in Adjuvant NSCLC Treatment Mean?

1.

Understanding Bone Metastases: How Long Can Someone Live When Cancer Spreads To The Bones?

2.

Everything You Need to Know About RDW-CV: A Comprehensive Guide 

3.

Evidence-Based Pathways for Survivorship Care Planning

4.

Breakthroughs in Cancer Care: From Rare Diagnoses to Advanced and Early-Stage Treatments

5.

Understanding the Role of CA 19-9 in Cancer Diagnosis and Treatment

1.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

2.

International Cancer Conference

3.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

4.

Asian Symposium on Advancement in Hematology and Oncology

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Guideline Recommendations of Lorlatinib as First-Line Treatment for ALK+ NSCLC

2.

Diagnosis and Management in Hematology

3.

Exploring Best Possible Treatment Strategies in Advanced Urothelial Carcinoma- A Panel Discussion

4.

Breast Cancer Awareness and Early Detection

5.

"Lorlatinib Upfront": A Niche but Powerful Option For ALK+ NSCLC

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot